Frederick K. Goodwin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Frederick K. Goodwin
Born (1936-04-21) April 21, 1936 (age 78)
Cincinnati, Ohio
Occupation Psychiatrist, Research professor
Spouse(s) Rosemary Goodwin, MSW

Frederick King Goodwin (born April 21, 1936)[1] is an American psychiatrist and Clinical Professor of Psychiatry at the George Washington University Medical Center,[2] where he is also director of the Center on Neuroscience, Medical Progress, and Society. He is a specialist in bipolar disorder (also known as manic-depressive illness) and recurrent depression.[3]

Life and career[edit]

Goodwin was born in Cincinnati, Ohio. He received a B.S. from Georgetown University in 1958 and his M.D. from St. Louis University in 1963, and was a psychiatric resident at the University of North Carolina in Chapel Hill. In 1965, Goodwin joined the National Institute of Mental Health (NIMH) and was its director from 1992 to 1994. Previously, he held a Presidential appointment as head of the Alcohol, Drug Abuse, and Mental Health Administration,[4] served as NIMH Scientific Director and Chief of Intramural Research from 1981 to 1988. He was the first to report a controlled study on the effects of lithium in bipolar disorder.[5][6]

He is a member of the Institute of Medicine of the National Academy of Sciences[7] and a fellow of the ACNP. He is a founder of the journal Psychiatry Research, and on the editorial boards of a number of other journals. He was president of the Psychiatric Research Society, elected in 1998.[8]

Goodwin is a recipient of the major research awards in his field including the Hofheimer Prize from the American Psychiatric Association, the International Anna-Monika Prize for Research in Depression, the Edward A. Strecker Award,[9] the Nola Maddox Falcone Prize from NARSAD (now known as the Brain & Behavior Research Foundation),[10] the McAlpin Research Award from the National Mental Health Association, the Distinguished Service Award from the National Alliance on Mental Illness, and the Research Award from the American Foundation for Suicide Prevention. He was the first recipient of the Psychiatrist of the Year from Psychiatric Times, and the Fawcett Humanitarian Award of the NDMDA (now the Depression and Bipolar Support Alliance. Goodwin was one of only five psychiatrists on the Current Contents list of the most frequently cited scientists in the world and one of 12 listed in The Best Doctors in the U.S.[11]

The Infinite Mind[edit]

In addition to his work at the George Washington University Medical Center and his private practice, Goodwin hosted the award-winning radio show The Infinite Mind. Started in 1997, the show (which at its height aired on over 300 public radio stations throughout the country), won more than 30 journalism awards over 10 years and was considered “public radio’s most honored and listened to health and science program."

Since retiring from government, Goodwin has been actively involved in educating other psychiatrists through continuing medical education (CME) programs and pharmaceutical speakers' bureaus. An article in The New York Times (Nov. 21, 2008)[12] said that Goodwin had hosted programs that recommended the use of drugs, without disclosing that he had received money from the manufacturers. Bill Lichtenstein, the senior executive producer of the show, said that Goodwin had not disclosed payments from pharmaceutical companies. However, Goodwin said that Lichtenstein was aware of his speaking and consulting activities for pharmaceutical companies, and that in 2005 Goodwin had switched to guest host and let Peter D. Kramer host other shows, including those discussing psychopharmacological treatment, for that reason. An assistant producer of The Infinite Mind independently supported Goodwin's claim.[13]

In 2008, Sen. Charles Grassley (IA-R) conducted investigations regarding possible conflicts of interest between various academic psychiatrists and pharmaceutical companies. Sen. Grassley found no impropriety regarding Goodwin.[citation needed] Goodwin issued a statement that The New York Times article and the follow-up editorial were filled with misstatements of fact and false implications.[14]

The Infinite Mind program, which was independently produced and distributed, was slated to end its production at the end of 2008 due to a lack of funding. Nevertheless, following the controversy, NPR cancelled the broadcast of reruns of the show on its Sirius Satellite Radio channel.[11]



With Kay Redfield Jamison, Goodwin wrote Manic-Depressive Illness, the first psychiatric text to win the "Best Medical Book" award from the Association of American Publishers and Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression. In addition, Dr. Goodwin has authored over 470 academic papers.


  1. ^ Goodwin, Frederick K (2003). Bipolar Disorder: Origin, Recognition, and Treatment. Volume 64, Issue 6 of Journal of clinical psychiatry: Supplement p. 38. eM Publications
  2. ^
  3. ^ Accessed on March 2, 2011
  4. ^ "New Director Named for Drug, Alcohol Research". July 12, 1988. 
  5. ^ Goodwin, FK; Murphy, DL; Bunney Jr, WE (October 1969). "Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study". Arch. Gen. Psychiatry 21 (4): 486–96. doi:10.1001/archpsyc.1969.01740220102012. PMID 4896983. 
  6. ^ Goodwin, FK; Murphy, DL; Dunner, DL; Bunney Jr, WE (July 1972). "Lithium response in unipolar versus bipolar depression". Am J Psychiatry 129 (1): 44–7. PMID 4556087. 
  7. ^
  8. ^
  9. ^ "Department of Psychiatry: Strecker Award Recipients". Retrieved 2012-05-22. 
  10. ^ [1][dead link]
  11. ^ a b "Bio". Dr. Goodwin. Retrieved 2012-05-22. 
  12. ^ Harris, Gardiner (November 22, 2008). "Radio Host Has Drug Company Ties". The New York Times. 
  13. ^ "Money Talks Transcript". On The Media. 2008-11-28. Retrieved 2012-05-22. 
  14. ^ "nyt". Dr. Goodwin. Retrieved 2012-05-22.